Clinical Trials · NCT01294371

Observational Program to Assess Routine Use of Add-back Therapy in Patients With Endometriosis in Russian Federation, Planned for 6-month Course of Lucrin Depot® (Leuprorelin)

Name: Observational Program to Assess Routine Use of Add-back Therapy in Patients With Endometriosis in Russian Federation, Planned for 6-month Course of Lucrin Depot® (Leuprorelin)
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/AGonadorelin

Phase: N/A
Recruitment status: Completed
Sponsor: AbbVie (prior sponsor, Abbott)
Enrollment: 391
Start date: Feb 2011
Locations: 28 sites, Russia
Primary endpoint: Percentage of Participants Administered Add-back Therapy During a 6-month Course of Leuprorelin Treatment

View Gonadorelin compound reference